{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-26-000210","form_type":"8-K","ticker":"PROF","cik":"0001628808","company_name":"Profound Medical Corp.","filed_at":"2026-01-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.681972+00:00","generated_at":"2026-05-16T10:52:51.932569+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Profound Medical TULSA-PRO installed base reaches 78 systems, exceeding 2025 target of 75","bullets":["TULSA-PRO installed base stood at 78 systems as of Dec. 31, 2025, above the goal of 75.","Qualified sales pipeline grew to 97 new systems in Verify, Negotiate, or Contracting stages.","CEO expects higher patient treatment rates and recurring revenue as installed base expands.","Q4 and full-year 2025 financial results to be released near end of February 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-26-000210","json":"https://secwatch.observer/filing/0001171843-26-000210.json","markdown":"https://secwatch.observer/filing/0001171843-26-000210.md","text":"https://secwatch.observer/filing/0001171843-26-000210.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1628808/000117184326000210/0001171843-26-000210-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1628808/000117184326000210/f8k_011226.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T10:52:51.932569+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}